Associations of serum uric acid level and gout with cardiac structure, function and sex differences from large scale
Kuo-Tzu Sung1,2,3, Chi-In Lo1,2,4, Yau-Huei Lai4,5
1Division of Cardiology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
Insights
Hyperuricemia (HU) and gout are linked to heart remodeling and diastolic dysfunction in Asians. Even low HU levels indicate poor heart health, with gout worsening the condition, especially in women.
Area of Science:
- Cardiology
- Metabolic Disorders
- Imaging and Diagnostics
Background:
- Hyperuricemia (HU) is a known marker for heart failure.
- Limited data exist on HU and gout's impact on cardiac remodeling and diastolic dysfunction (DD) in Asian populations.
Purpose of the Study:
- To investigate the association between HU, gout, and cardiac structure/function in asymptomatic Asian adults.
- To determine if HU and gout are linked to adverse cardiac remodeling and DD.
Main Methods:
- Cross-sectional study of 5525 asymptomatic Asian individuals.
- Categorization into Non-HU, HU, and Gout groups.
- Assessment of cardiac structure and diastolic function using echocardiography, including tissue Doppler imaging (TDI)-derived LV e' and E/e'.
Main Results:
- Higher serum uric acid (SUA) levels and gout were associated with increased LV wall thickness, mass, LA volume, and impaired diastolic function (lower LV e', higher E/e').
- HU and Gout groups showed significantly higher DD risk (ORs 1.21 and 1.91, respectively).
- A SUA cutoff of 7.0 mg/dL optimally identified DD; women with HU/gout exhibited worse diastolic indices than men.
Conclusions:
- Hyperuricemia, even at sub-clinical levels, is associated with unfavorable cardiac remodeling and diastolic dysfunction.
- Gout presence exacerbates these cardiac abnormalities.
- Women with HU or gout experience more severe diastolic dysfunction compared to men, irrespective of cardiac remodeling severity.
Abstract:
Hyperuricemia (HU) is a marker for heart failure. There are relatively few data in the Asian population regarding the effects of hyperuricemia and gouty disorders on cardiac remodeling and diastolic dysfunction (DD), an intermediate stage in the development of heart failure. We consecutively recruited asymptomatic Asian individuals to undergo cardiovascular surveys. We categorized them into Non-HU, HU, and Gout groups. We measured cardiac structure and indices for diastolic function, including tissue Doppler (TDI)-derived LV e' and E/e'. Among 5525 participants, 1568 had HU and 347 had gout. The presence of gout and higher uric acid levels (SUA) (<4, 4-6, 6-8, 8-10, > = 10 mg/dL) were associated with greater LV wall thickness, greater LV mass/volumes, larger LA volume, lower LV e' and higher E/e'. Higher SUA was associated with greater LV mass index (adjusted coefficient: 0.37), greater mass/volume ratio (adjusted coefficient: 0.01) and larger LA volume index (adjusted coefficient: 0.39, all p<0.05). Both HU and Gout groups were associated with lower LV e' (coefficient: -0.086, -0.05), higher E/e' (coefficient: 0.075, 0.35, all p <0.05), larger LA volume, and higher DD risk (adjusted ORs: 1.21 and 1.91 using Non-HU as reference, respectively, both p <0.05). SUA set at 7.0 mg/dL provided the optimal cut-off for identifying DD, with markedly lower e' (HU: 8.94 vs 8.07, Gout: 7.94 vs 7.26 cm/sec) and higher LV E/e' in HU/Gout women than in men (HU: 7.84 vs 9.79 cm/sec for men and women, respectively, all p <0.05). Hyperuricemia, even at a relatively low clinical cut-off, was associated with unfavorable remodeling and was tightly linked to diastolic dysfunction. The presence of gout likely aggravated these conditions. Women with hyperuricemia or gout had worse diastolic indices than men despite similar degrees of LV remodeling.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests


